Home › Ewing Sarcoma › Alabama › Birmingham
Ewing Sarcoma clinical trials in Birmingham, AL
5 studies for Ewing Sarcoma are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
RecruitingPhase 1
- University of Alabama at Birmingham (Children's of Alabama), Birmingham
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- University of Alabama/Children's of Alabama, Birmingham
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- University of Alabama/Children's of Alabama, Birmingham
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's Hospital of Alabama, Birmingham
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RecruitingPhase 2
- Children's Hospital of Alabama/UAB, Birmingham
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Houston, TX7 studies
- Philadelphia, PA7 studies
- Memphis, TN7 studies
- Aurora, CO6 studies
- Boston, MA6 studies
- Los Angeles, CA6 studies
- Washington, DC6 studies
- Atlanta, GA5 studies
- Cincinnati, OH4 studies
- Phoenix, AZ4 studies
- Columbus, OH4 studies
Other studies in Birmingham
- Cancer (all types)31 studies
- Breast Cancer24 studies
- Obesity24 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- COPD18 studies
- Multiple Myeloma18 studies
- Overweight17 studies
- Cardiovascular Disease17 studies
- Type 2 Diabetes16 studies
- Endometrial Cancer16 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.